232 related articles for article (PubMed ID: 30554527)
1. Pharmacovigilance in India in Comparison With the USA and European Union: Challenges and Perspectives.
Jose J; Rafeek NR
Ther Innov Regul Sci; 2019 Nov; 53(6):781-786. PubMed ID: 30554527
[TBL] [Abstract][Full Text] [Related]
2. Pharmacovigilance in India, Uganda and South Africa with reference to WHO's minimum requirements.
Maigetter K; Pollock AM; Kadam A; Ward K; Weiss MG
Int J Health Policy Manag; 2015 Mar; 4(5):295-305. PubMed ID: 25905480
[TBL] [Abstract][Full Text] [Related]
3. Pharmacovigilance in oncology: evaluation of current practice and future perspectives.
Baldo P; De Paoli P
J Eval Clin Pract; 2014 Oct; 20(5):559-69. PubMed ID: 24909067
[TBL] [Abstract][Full Text] [Related]
4. Pharmacovigilance in India: Present Scenario and Future Challenges.
Kalaiselvan V; Srivastava S; Singh A; Gupta SK
Drug Saf; 2019 Mar; 42(3):339-346. PubMed ID: 30269244
[TBL] [Abstract][Full Text] [Related]
5. Adverse event reporting tools and regulatory measures in India through outcome of Pharmacovigilance Programme of India.
Prakash J; Sachdeva R; Shrivastava TP; Jayachandran CV; Sahu A
Indian J Pharmacol; 2021; 53(2):143-152. PubMed ID: 34100398
[TBL] [Abstract][Full Text] [Related]
6. Development of Pharmacovigilance System in India and Paradigm of Pharmacovigilance Research: An Overview.
Singh P; Vaishnav Y; Verma S
Curr Drug Saf; 2023; 18(4):448-464. PubMed ID: 36200243
[TBL] [Abstract][Full Text] [Related]
7. Safety reporting through a comprehensive and pragmatic pharmcovigilance process for India and emerging markets: an industry perspective.
Swamy S; Mourya M; Kadhe G; Mane A; Sawant S
Expert Opin Drug Saf; 2015; 14(9):1409-20. PubMed ID: 26292785
[TBL] [Abstract][Full Text] [Related]
8. Knowledge, Attitude, and Practices regarding Pharmacovigilance and Adverse Drug Reaction reporting among Dental Students in a Teaching Hospital, Jodhpur, India: A Cross-sectional Study.
Chhabra KG; Sharma A; Chhabra C; Reddy JJ; Deolia SG; Mittal Y
J Contemp Dent Pract; 2017 Oct; 18(10):964-969. PubMed ID: 28989138
[TBL] [Abstract][Full Text] [Related]
9. Overview of pharmacovigilance practices at the largest academic healthcare system in the State of Qatar.
Al Hail M; Elkassem W; Hamad A; Abdulrouf P; Thomas B; Stewart D
Int J Clin Pharm; 2018 Aug; 40(4):769-774. PubMed ID: 29616393
[TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of the pharmacovigilance systems of Brazil, Spain, the European Union and the United States based on the information provided by their regulatory agency websites.
Leal MM; Sanz MM; Ferrando JRC; Martinez-Martinez F
Daru; 2019 Jun; 27(1):379-387. PubMed ID: 30778915
[TBL] [Abstract][Full Text] [Related]
11. Veterinary pharmacovigilance in India: A need of hour.
Kumar R; Kalaiselvan V; Verma R; Kaur I; Kumar P; Singh GN
Indian J Pharmacol; 2017; 49(1):2-3. PubMed ID: 28458414
[TBL] [Abstract][Full Text] [Related]
12. Role of Pharmacovigilance in India: An overview.
Suke SG; Kosta P; Negi H
Online J Public Health Inform; 2015; 7(2):e223. PubMed ID: 26392851
[TBL] [Abstract][Full Text] [Related]
13. What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects.
van Eekeren R; Rolfes L; Koster AS; Magro L; Parthasarathi G; Al Ramimmy H; Schutte T; Tanaka D; van Puijenbroek E; Härmark L
Drug Saf; 2018 Nov; 41(11):1003-1011. PubMed ID: 29949100
[TBL] [Abstract][Full Text] [Related]
14. National pharmacovigilance programs in Arab countries: A quantitative assessment study.
Alshammari TM; Alenzi KA; Ata SI
Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1001-1010. PubMed ID: 32181540
[TBL] [Abstract][Full Text] [Related]
15. Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.
Jusot V; Chimimba F; Dzabala N; Menang O; Cole J; Gardiner G; Ofori-Anyinam O; Oladehin O; Sambakunsi C; Kawaye M; Stegmann JU; Guerra Mendoza Y
Drug Saf; 2020 Jun; 43(6):583-593. PubMed ID: 32239447
[TBL] [Abstract][Full Text] [Related]
16. Medicines for Europe - 13th Pharmacovigilance Conference (January 29, 2020 - Amsterdam, the Netherlands).
Hamaui Cuadrado S
Drugs Today (Barc); 2020 Feb; 56(2):165-168. PubMed ID: 32163531
[TBL] [Abstract][Full Text] [Related]
17. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
[TBL] [Abstract][Full Text] [Related]
18. Pharmacovigilance in Russia: current state of affairs, challenges, and prospects.
Gildeeva G; Belostotsky A
Curr Med Res Opin; 2017 Dec; 33(12):2161-2166. PubMed ID: 28562116
[TBL] [Abstract][Full Text] [Related]
19. Medicine Safety Monitoring in Pediatric Population in India.
Kaur I; Kalaiselvan V; Singh GN
Indian J Pediatr; 2016 May; 83(5):479-80. PubMed ID: 26634262
[No Abstract] [Full Text] [Related]
20. Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union.
Inácio P; Cavaco A; Allan E; Airaksinen M
Public Health; 2018 Feb; 155():119-128. PubMed ID: 29346070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
